<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37512160</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1648-9144</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>23</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>Persistent Pancytopenia as a Long-COVID Manifestation in a Patient with Adult-Onset Still's Disease: A Case Report.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1349</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medicina59071349</ELocationID><Abstract><AbstractText><i>Background:</i> Adult-onset Still's disease (AOSD) is a rare rheumatic inflammatory condition with an extremely heterogeneous clinical presentation and systemic impairment. Uncommon manifestations may be challenging to manage, especially in patients with previous severe acute SARS-CoV-2 infection. For the first time, we report the case of a patient affected by refractory AOSD presenting with severe pancytopenia as a long-COVID manifestation. The purpose of this case report is to illustrate the clinical presentation, diagnostic and therapeutic management of this unusual manifestation. Moreover, we examine the mechanisms that are potentially responsible for the onset of the pancytopenia observed in our patient. <i>Case presentation:</i> We describe the case of a 40-year-old male who presented with a history of fever for 2 years, arthralgia, maculopapular salmon-pink rash and a previous SARS-CoV-2 infection which required admission to intensive care. The patient's laboratory results revealed elevated inflammatory markers levels (erythrocyte sedimentation rate and C-reactive protein), hyperferritinemia and severe pancytopenia that needed multiple transfusions. A diagnosis of AOSD was made based on clinical and laboratory presentation after excluding neoplastic, infectious and other rheumatic diseases. The previous empirical treatment was not adequate to control the condition; therefore, treatment with high-dose steroids, canakinumab and epoetin alfa was started and led to the resolution of the man's symptoms and a reduction in inflammatory marker levels, whereas blood cell count remained stable without a need for further blood transfusions. The patient is currently under rheumatologic and hematologic follow-up every month. <i>Conclusions:</i> Neither AOSD nor SARS-CoV-2 infection usually manifests with pancytopenia, except in hemophagocytic syndrome or immunodeficient patients, respectively. Identifying the underlying etiology of pancytopenia is mandatory to establish a prompt treatment that generally resolves the disorder. However, in our case, all common causes of pancytopenia were excluded, suggesting a potential manifestation of the long-COVID syndrome. Despite the resolution of the acute infection and the remarkable treatment of AOSD, pancytopenia persists. Herein, we propose for refractory AOSD patients with previous SARS-CoV-2 infection a novel approach to the diagnosis and treatment of pancytopenia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Massimino</LastName><ForeName>Mattia</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3533-939X</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, "Magna Gr&#xe6;cia" University of Catanzaro, 88100 Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iaquinta</LastName><ForeName>Francesco Salvatore</ForeName><Initials>FS</Initials><Identifier Source="ORCID">0000-0001-9740-1203</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences, "Magna Gr&#xe6;cia" University of Catanzaro, 88100 Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naty</LastName><ForeName>Saverio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, "Magna Gr&#xe6;cia" University of Catanzaro, 88100 Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreozzi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9375-1513</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, "Magna Gr&#xe6;cia" University of Catanzaro, 88100 Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grembiale</LastName><ForeName>Rosa Daniela</ForeName><Initials>RD</Initials><Identifier Source="ORCID">0000-0002-0338-6784</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences, "Magna Gr&#xe6;cia" University of Catanzaro, 88100 Catanzaro, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016706" MajorTopicYN="Y">Still's Disease, Adult-Onset</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010198" MajorTopicYN="Y">Pancytopenia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Still&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">adult-onset</Keyword><Keyword MajorTopicYN="N">pancytopenia</Keyword><Keyword MajorTopicYN="N">rheumatology</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37512160</ArticleId><ArticleId IdType="pmc">PMC10384992</ArticleId><ArticleId IdType="doi">10.3390/medicina59071349</ArticleId><ArticleId IdType="pii">medicina59071349</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Giacomelli R., Ruscitti P., Shoenfeld Y. A comprehensive review on adult onset Still&#x2019;s disease. J. Autoimmun. 2018;93:24&#x2013;36. doi: 10.1016/j.jaut.2018.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.07.018</ArticleId><ArticleId IdType="pubmed">30077425</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M.-Y., Jia J.-C., Yang C.-D., Hu Q.-Y. Pathogenesis, disease course, and prognosis of adult-onset Still&#x2019;s disease: An update and review. Chin. Med. J. 2019;132:2856&#x2013;2864. doi: 10.1097/CM9.0000000000000538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000538</ArticleId><ArticleId IdType="pmc">PMC6940076</ArticleId><ArticleId IdType="pubmed">31856058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadavath S., Efthimiou P. Adult-onset Still&#x2019;s disease-pathogenesis, clinical manifestations, and new treatment options. Ann. Med. 2015;47:6&#x2013;14. doi: 10.3109/07853890.2014.971052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853890.2014.971052</ArticleId><ArticleId IdType="pubmed">25613167</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi M., Ohta A., Tsunematsu T., Kasukawa R., Mizushima Y., Kashiwagi H., Kashiwazaki S., Tanimoto K., Matsumoto Y., Ota T. Preliminary criteria for classification of adult Still&#x2019;s disease. J. Rheumatol. 1992;19:424&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">1578458</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Guo H., Zhou P., Shi Z.-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19:141&#x2013;154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnanaraj J., Parnes A., Francis C.W., Go R.S., Takemoto C.M., Hashmi S.K. Approach to pancytopenia: Diagnostic algorithm for clinical hematologists. Blood Rev. 2018;32:361&#x2013;367. doi: 10.1016/j.blre.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2018.03.001</ArticleId><ArticleId IdType="pubmed">29555368</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute for Health and Care Excellence (NICE); London, UK: 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.-Y., Li L., Zhang Y., Wang X.-S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty. 2020;9:45. doi: 10.1186/s40249-020-00662-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId><ArticleId IdType="pmc">PMC7186534</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., He J., Wang J., Li W.M., Xu M., Yu X., Wu W., Sun C., Xu Z., Zhang W., et al. Development of pancytopenia in a patient with COVID-19. J. Med. Virol. 2021;93:1219&#x2013;1220. doi: 10.1002/jmv.26566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26566</ArticleId><ArticleId IdType="pmc">PMC7537507</ArticleId><ArticleId IdType="pubmed">32990983</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridwell R.E., Inman B.L., Birdsong S., Goss S., Long B. A coronavirus disease-2019 induced pancytopenia. Am. J. Emerg. Med. 2021;47:e1&#x2013;e324. doi: 10.1016/j.ajem.2020.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.12.030</ArticleId><ArticleId IdType="pmc">PMC7902224</ArticleId><ArticleId IdType="pubmed">33653644</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N., Shukla R., Warrier R., Kumar K., Singh N., Ghose S., Kumar V. Pancytopenia Secondary to SARS-CoV-2 Infection-a Case Report. SN Compr. Clin. Med. 2022;4:31. doi: 10.1007/s42399-021-01085-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-021-01085-x</ArticleId><ArticleId IdType="pmc">PMC8743232</ArticleId><ArticleId IdType="pubmed">35036849</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersby D.S., Do T.H., Gang A.O., Nielsen T.H. COVID-19-associated pancytopenia can be self-limiting and does not necessarily warrant bone marrow biopsy for the purposes of SARS-CoV-2 diagnostics. Ann. Oncol. 2021;32:121&#x2013;123. doi: 10.1016/j.annonc.2020.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annonc.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7527792</ArticleId><ArticleId IdType="pubmed">33011227</ArticleId></ArticleIdList></Reference><Reference><Citation>Issa N., Lacassin F., Camou F. First case of persistent pancytopenia associated with SARS-CoV-2 bone marrow infiltration in an immunocompromised patient. Ann. Oncol. 2020;31:1418&#x2013;1419. doi: 10.1016/j.annonc.2020.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annonc.2020.06.016</ArticleId><ArticleId IdType="pmc">PMC7323636</ArticleId><ArticleId IdType="pubmed">32615155</ArticleId></ArticleIdList></Reference><Reference><Citation>Nawar T., Morjaria S., Kaltsas A., Patel D., Perez-Johnston R., Daniyan A.F., Mailankody S., Parameswaran R. Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow? Am. J. Hematol. 2020;95:E210&#x2013;E213. doi: 10.1002/ajh.25870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25870</ArticleId><ArticleId IdType="pmc">PMC7276914</ArticleId><ArticleId IdType="pubmed">32419212</ArticleId></ArticleIdList></Reference><Reference><Citation>Konopka K.E., Perry W., Huang T., Farver C.F., Myers J.L. Usual Interstitial Pneumonia is the Most Common Finding in Surgical Lung Biopsies from Patients with Persistent Interstitial Lung Disease Following Infection with SARS-CoV-2. EClinicalMedicine. 2021;42:101209. doi: 10.1016/j.eclinm.2021.101209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101209</ArticleId><ArticleId IdType="pmc">PMC8609167</ArticleId><ArticleId IdType="pubmed">34841234</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccio U., Zinkernagel A.S., Schuepbach R., Probst-Mueller E., Frontzek K., Brugger S.D., Hofmaenner D.A., Moch H., Varga Z. Long-Term Persisting SARS-CoV-2 RNA and Pathological Findings: Lessons Learnt From a Series of 35 COVID-19 Autopsies. Front. Med. 2022;9:778489. doi: 10.3389/fmed.2022.778489.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.778489</ArticleId><ArticleId IdType="pmc">PMC8865372</ArticleId><ArticleId IdType="pubmed">35223894</ArticleId></ArticleIdList></Reference><Reference><Citation>Huseynov A., Akin I., Duerschmied D., Scharf R.E. Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment. Viruses. 2023;15:389. doi: 10.3390/v15020389.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020389</ArticleId><ArticleId IdType="pmc">PMC9959721</ArticleId><ArticleId IdType="pubmed">36851603</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha A.B., Mehta A., Pokharel P., Mishra A., Adhikari L., Shrestha S., Yadav R.S., Khanal S., Sah R., Nowrouzi-Kia B., et al. Long COVID Syndrome and Cardiovascular Manifestations: A Systematic Review and Meta-Analysis. Diagnostics. 2023;13:491. doi: 10.3390/diagnostics13030491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13030491</ArticleId><ArticleId IdType="pmc">PMC9913936</ArticleId><ArticleId IdType="pubmed">36766599</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., Guis S., Barthelemy F., Habert P., Ceccaldi M., et al. 18F-FDG brain PET hypometabolism in patients with long, COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E., Gavriatopoulou M., Fotiou D., Ntanasis-Stathopoulos I., Dimopoulos M.A., Terpos E. Late-onset hematological complications post COVID-19: An emerging medical problem for the hematologist. Am. J. Hematol. 2022;97:119&#x2013;128. doi: 10.1002/ajh.26384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26384</ArticleId><ArticleId IdType="pmc">PMC8646944</ArticleId><ArticleId IdType="pubmed">34687462</ArticleId></ArticleIdList></Reference><Reference><Citation>Okayasu T., Ohta R., Igarashi M., Kurita Y., Hayakawa M., Sano C. Coexistence of Pancytopenia and Myositis After Developing COVID-19. Cureus. 2022;14:e26978. doi: 10.7759/cureus.26978.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.26978</ArticleId><ArticleId IdType="pmc">PMC9385165</ArticleId><ArticleId IdType="pubmed">35989844</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K., Dansoa Y., Pathak P. Pancytopenia with Development of Persistent Neutropenia Secondary to COVID-19. Case Rep. Hematol. 2022;2022:8739295. doi: 10.1155/2022/8739295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/8739295</ArticleId><ArticleId IdType="pmc">PMC9092211</ArticleId><ArticleId IdType="pubmed">35571527</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>